Ordentlich Peter

CIK 00015942741 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001594274

Recent Transactions

46 trades

Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-15$25.84/sh−7,572→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-15$25.84/sh−17,428→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-02-15$25.84/sh−17,428→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-15$7.20/sh+17,428→ 17,428 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-02-15$25.84/sh−7,572→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-15$6.38/sh+7,572→ 7,572 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-02-02$28.55/sh+90,000→ 90,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-01$28.43/sh−69→ 0 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-31$17.32/sh+69→ 69 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-02$6.38/sh+17,200→ 17,465 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-02$25.05/sh−17,200→ 265 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-12-02−17,200→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-01$25.01/sh−4,028→ 265 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-12-01−4,028→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-01$25.01/sh−3,772→ 265 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-12-01−3,772→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-01$6.35/sh+3,772→ 4,037 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-12-01$6.38/sh+4,028→ 4,293 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-08-24−2,154→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-08-24−22,846→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-24$6.35/sh+2,154→ 2,419 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-24$25.04/sh−22,846→ 265 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-24$6.32/sh+22,846→ 23,111 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-24$25.04/sh−2,154→ 265 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-07-29$14.12/sh+265→ 265 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-02-02$15.79/sh+80,000→ 80,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-01$16.65/sh−1,412→ 0 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-01-31$12.39/sh+1,412→ 1,412 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2021-02-03+80,000→ 80,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-11-23$22.89/sh−16,334→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-11-23$23.58/sh−7,954→ 16,334 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-11-23$3.08/sh+24,288→ 24,288 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-11-23$3.08/sh+5,684→ 29,972 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-11-23−5,684→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-11-23$23.33/sh−5,684→ 24,288 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-11-23−24,288→ 0 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-02-12+50,000→ 50,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2019-02-06+80,000→ 80,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2018-04-03$15.00/sh−7,500→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Employee Stock Option (right to buy)
2018-04-03−7,500→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2018-04-03$3.08/sh+7,500→ 7,500 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-03-01+40,000→ 40,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2017-05-17$3.08/sh+732→ 5,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Employee Stock Option (right to buy)
2017-05-17−732→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2017-05-17$15.00/sh−5,000→ 0 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-02-06+20,000→ 20,000 total

Companies

Syndax Pharmaceuticals Inc
Chief Technology Officer
$SNDX

Recent Filings

Address

C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110

WALTHAM, MA, 02451

View on SEC.gov